Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

Investors allege ARS misled them about neffy insurance coverage timing, and the suit seeks compensation for buyers during the class period.

  • Rosen Law Firm announced a class action lawsuit on behalf of ARS Pharmaceuticals investors who purchased securities between March 9, 2026, and June 24, 2026, seeking to represent shareholders who suffered financial damages.
  • The lawsuit alleges defendants concealed adverse facts regarding neffy's "expected timeline for expanded insurance coverage" with CVS Caremark, causing shareholders to purchase ARS Pharmaceuticals securities at artificially inflated prices.
  • Investors wishing to serve as lead plaintiff must move the Court by October 5, 2026; a lead plaintiff acts as a representative party directing the litigation on behalf of other class members.
  • Purchasers during the Class Period may receive compensation without out-of-pocket costs through a contingency fee arrangement, and investors may remain absent class members or select personal counsel until certification.
  • Founding partner Laurence Rosen was named a "Titan of Plaintiffs' Bar" in 2020; investors can contact attorney Phillip Kim toll-free at 866-767-3653 or email case@rosenlegal.com for case information.
Insights by Ground AI

39 Articles

Williamson HeraldWilliamson Herald
+28 Reposted by 28 other sources
Center

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 16, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June…

Bennington BannerBennington Banner
+6 Reposted by 6 other sources
Center

DVLT Investors Have Opportunity to Lead Datavault AI Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 16, 2026 /PRNewswire/ -

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 78% of the sources are Center
78% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

NewMediaWire broke the news on Sunday, August 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal